{"url":"https://lda.senate.gov/api/v1/filings/2da7a04a-19ea-48c4-92a8-e516b46afebf/","filing_uuid":"2da7a04a-19ea-48c4-92a8-e516b46afebf","filing_type":"RA","filing_type_display":"Registration - Amendment","filing_year":2025,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/2da7a04a-19ea-48c4-92a8-e516b46afebf/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John Billington","dt_posted":"2025-11-25T13:59:34-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Campus Drive","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Florham Park","registrant_state":"NJ","registrant_zip":"07932","registrant":{"id":401107081,"url":"https://lda.senate.gov/api/v1/registrants/401107081/","house_registrant_id":55822,"name":"SHIONOGI INC.","description":null,"address_1":"400 Campus Drive","address_2":null,"address_3":null,"address_4":null,"city":"Florham Park","state":"NJ","state_display":"New Jersey","zip":"07932","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAHLET MAKONNEN","contact_telephone":"+1 202-973-5964","dt_updated":"2026-01-20T15:20:41.182055-05:00"},"client":{"id":53361,"url":"https://lda.senate.gov/api/v1/clients/53361/","client_id":53361,"name":"SHIONOGI INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-10-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 and S. 2076)","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 and S. 2076)","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 and S. 2076)","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 and S. 2076)","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 and S. 2076)","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 and S. 2076)","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 and S. 2076)","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":152151,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"BILLINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[{"name":"SHIONOGI & COMPANY, LIMITED","contribution":"0.00","ownership_percentage":"100.00","address":"3-1-8, DOSHOMACHI, CHUO-KU OSAKA","city":"Osaka","state":null,"state_display":null,"country":"JP","country_display":"Japan","ppb_city":"Osaka","ppb_state":null,"ppb_state_display":null,"ppb_country":"JP","ppb_country_display":"Japan"}],"affiliated_organizations":[]}